Souhaitez-vous accéder aux communiqués récents ?

NEW YORK e SAVONA, Italia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, una divisione di Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) e leader mondiale nel settore della cannabis...

NEW YORK und SAVONA, Italien, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray“) (Nasdaq: TLRY; TSX: TLRY) und ein weltweit führender Anbieter...

NEW YORK et SAVONE, Italie, 22 janv. 2026 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (« Tilray ») (Nasdaq : TLRY ; TSX : TLRY) et leader mondial du cannabis...

HAIFA, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a biotechnology company leveraging its proprietary platform for cell-based...

Delray Beach, FL, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The Global orthopedic biomaterials market is projected to reach USD 24.86 billion by 2030 from USD 16.95 billion in 2025, at a CAGR of 8.0% from...

CARMEL, Ind., Jan. 22, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel...

Series D1 financing with participation from a syndicate of global healthcare-focused investors, including RTW Investments, SR One Capital Management (SR One), TCG Crossover (TCGX), RA Capital...

Amendment reduces and simplifies royalty structure on Teverelix® from ~4% to 2% while preserving global rights and IP control The Company is developing Teverelix® as a first in class market product...

Toronto, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Diabetes Canada is proud to announce the winners of its End Diabetes Awards, an annual competition that aims to improve the lives of people living with, or...

AI Disruption: A Global Overview,” artificial Intelligence is redefining the very foundations of industry and society.